1. Home
  2. SNGX vs AUID Comparison

SNGX vs AUID Comparison

Compare SNGX & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.39

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.76

Market Cap

14.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
AUID
Founded
1987
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
14.4M
14.2M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
SNGX
AUID
Price
$1.39
$1.76
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
195.6K
15.7M
Earning Date
11-07-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,834,458.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
141.81
52 Week Low
$1.09
$0.84
52 Week High
$6.23
$9.58

Technical Indicators

Market Signals
Indicator
SNGX
AUID
Relative Strength Index (RSI) 47.26 66.60
Support Level $1.35 $1.37
Resistance Level $1.46 $2.45
Average True Range (ATR) 0.08 0.22
MACD 0.01 0.10
Stochastic Oscillator 31.25 54.56

Price Performance

Historical Comparison
SNGX
AUID

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

Share on Social Networks: